Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants

Cytokine

Volumn 8, Issue 6, 1996, Pages 495-500

  Hui, Wang ^a   Bell, Michael ^a   Carroll, Graeme ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Cartilage; Cytokines; Growth factors; Oncostatin M; Proteoglycan

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 130; METHYLENE BLUE; ONCOSTATIN M; PAPAIN; PROTEOGLYCAN;

ARTICLE; ARTICULAR CARTILAGE; CARBOHYDRATE METABOLISM; CARTILAGE; CARTILAGE GRAFT; EXPLANT; NONHUMAN; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; RADIOACTIVITY; RHEUMATOID ARTHRITIS; SWINE;

CAPRA HIRCUS; SUIDAE; SUS SCROFA;

EID: 0030175403     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0067     Document Type: Article

References (51)

1. 1. Harris ED Jr (1989) Pathogenesis of Rheumatoid Arthritis, Textbook of Rheumatology. 3rd Edition. Edited by WN Kelley, ED Harris Jr, S Ruddy, CB Sledge. Philadelphia, WB Saunders.
2. 2. Harris ED (1990) Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 322:1277-1289.
3. 3. Morales TI, Hascall VC (1989) Factors involved in the regulation of proteoglycan metabolism in articular cartilage. Arthritis Rheum 32:1197-1201.
4. 4. Nietfeld JJ, Wilbrink B, van der Otter W, Huber J, Huber-Bruning O (1990) Factors involved in the regulation of proteoglycan metabolism in articular cartilage. J Rheumatol 17:818-826.
5. 5. Pettipher ER, Higgs GA, Henderson B (1986) Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 83:8749-8753.
6. 6. Van Beuringen HM, Arntz OJ, Van den Berg WB (1991) In vivo effects of interleukin-1 on cartilage. Arthritis Rheum 34:606-615.
7. 7. Tyler JA (1988) The influence of IL-1 and IGF-1 on the integrity of cartilage matrix. In Glauart A (ed), The control of tissue damage. Elsevier, Amsterdam, pp 197-214.
8. 8. Saklatvala J (1986) Tumour necrosis factor stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547-549.
9. 9. Tyler JA (1989) Insulin like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J 260:543-548.
10. 10. Morales TI (1991) Transforming growth factor beta stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. Arch Biochem Biophys 286:99-106.
11. 11. Dubios CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR (1990) Transforming growth factor beta is a potent inhibitor or interleukin-1 receptor expression: proposed mechanism for the inhibition of IL-1 action. J Exp Med 172:737-744.
12. 12. Carroll GJ, Bell MC (1993) Leukaemia inhibitory factor stimulates proteoglycan resorption in porcine articular cartilage. Rheumatol Int 13:5-8.
13. 13. Bell MC, Carroll GJ (1995) Leukaemia inhibitory factor (LIF) suppresses proteoglycan synthesis in porcine and caprine cartilage explants. Cytokine 7:137-141.
14. 14. Carroll GJ, Bell MC, Chapman HM, Mills JN, Robinson WF (1995) Leukaemia inhibitory factor (LIF) induces leukocyte infiltration and cartilage proteoglycan degradation in goat joints. J Interferon and Cytokine Res 15: 567-573.
15. 15. Malik N, Kallestad JC, Gunderson NL, Austin SD, Neubauer MG, Ochs V, Marquardt H, Zarling JM, Shoyab M, Wei CM, Linsley PS, Rose TM (1989) Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, Oncostatin M. Mol Cell Biol 9:2847-2851.
16. 16. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ (1986) Oncostatin M: a growth regulator produced by differentiated histiocyte lymphoma cells. Proc Natl Acad Sci USA 83:9739-9743.
17. 17. Brown TJ, Lioubin MN, Marquardt H (1987) Purification and characterisation of cytostatic lymphokines produced by activated human T lymphocytes. J Immunol 139:2977-2983.
18. 18. Grove R I, Mazzucco C, Allegretto N, Keiner RA, Spitalay G, Radka SF, Shoyab M, Antonaccio M, Warr GA (1991) Macrophage-derived factors increase low density lipoprotein uptake and receptor number in cultured human liver cells. J Lipid Res 32:1889-1897.
19. 19. Kishimoto T, Akira S, Taga T (1992) Interleukin-6 and its receptor: A paradigm for cytokines. Science 258:593-597.
20. 20. Hirano T, Matsuda T, Nakajima K (1994) Signal transduction through gp130 that is shared among the receptors for the Interleukin-6 related cytokine subfamily. Stem Cells 12:262-277.
21. 21. Rose TM, Bruce AG (1991) Oncostatin M is a member of a cytokine family that includes leukemia inhibitory factor, granulocyte colony stimulating factor, and interleukin 6. Proc Natl Acad Sci USA 88:8641-8645.
22. 22. Metcalf D (1989) Actions and interactions of G-CSF, LIF and IL-6 on normal and leukemia murine cells. Leukemia 3:349-355.
23. 23. Musashi M, Yang YC, Paul SR, Clark SC, Sudo T, Ogawa M (1991) Direct and synergistic effects of Interleukin-11 on murine hemopoiesis in culture. Proc Natl Acad Sci USA 88:765-769.
24. 24. Taga T, Narazaki M, Yasukawa K, Saito T, Miki D, Hamaguchi M, Davis S, Shoyab M, Yancopolous GD, Kishimoto T (1992) Functional inhibition of hematopoietic and neurotrophic cytokines by blocking IL-6 signal transducer, gp130. Proc Natl Acad Sci USA 89:10998-11001.
25. 25. Baumann H, Wong GG (1989) Hepatocyte-stimulatory factor III shares structural and functional identity with leukemia inhibitory factor. J Immunol 143:1163-1167.
26. 26. Richards CD, Brown TJ, Shoyab M, Baumann H, Gauldie J (1992) Recombinant oncostatin M stimulates the production of acute phase protein in HepG2 cells and rat primary hepatocytes in vitro. J Immunol 148:1731-1736.
27. 27. Baumann H, Schendel P (1991) Interleukin 11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem 266:20424-20427.
28. 28. Patterson PH, Nawa H (1993) Neuronal differentiation factor/cytokine and synaptic plasticity. Cell 72:123-137.
29. 29. Leary AG, Zeng HQ, Clark SC, Ogawa M (1992) Growth factor requirements for survival in Go and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci USA 89:4013-4017.
30. 30. Reid IR, Lowe C, Cornish J, Skinner SJM, Hilton DJ, Willson TA, Gearing DP, Martin TJ (1990) Leukaemia inhibitory factor: A novel bone-active cytokine. Endocrinology 126:1416-1420.
31. 31. Ishimi Y, Miyaura C, He Jin C, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T (1990) IL-6 is produced by osteoclasts and induces bone resorption. J Immunol 145:3297-3303.
32. 32. Taga T, Hib M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T (1989) Interleukin 6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573-581.
33. 33. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gill S, Mosley B, Ziegler SF, Cosman D (1992) The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434-1437.
34. 34. Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, Stahl N, Yancopoulos GD (1992) CNTF and LIF act on neuronal cells via shared signalling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69:1121-1132.
35. 35. Zhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B (1994) Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med 177:1337-1342.
36. 36. Yin T, Taga T, Tsang MLS, Yasukawa K, Kishimoto T, Yang Y-C (1993) Involvement of IL-6 signal transducer gp130 in IL-11 mediated signal transduction. J Immunol 151:2555-2561.
37. 37. Jeffery E, Price V, Gearing DP (1993) Close proximity of the genes for leukemia inhibitory factor and oncostatin M. Cytokine 5:107-111.
38. 38. Nietfeld JJ, Wilbrink B, Helle M, van Roy JLAM, den Otter W, Swaak AJG, Huber-Bruning O (1990) Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage. Arthritis Rheum 33:1695-1701.
39. 39. Nietfeld JJ, Duits AJ, Tilanus MGJ, van den Bosch ME, den Otter W, Capel PJA, Bijlsma JWJ (1994) Antisense oligonucleotides, A novel tool for the control of cytokine effects on human cartilage. Arthritis Rheum 37:1357-1362.
40. 40. Shingu M, Isayama T, Yasutake C, Naono T, Nobunaga M, Tomari K, Horie K, Goto Y (1994) Role of oxygen radicals and IL-6 in IL-1-dependent cartilage matrix degradation. Inflammation 18(6):613-623.
41. 41. van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB (1995) Role of interleukin-1, tumor necrosis factor a, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Arthritis Rheum 38(2): 164-172.
42. 42. Richards CD, Shoyab M, Brown TJ, Gauldie J (1993) Selective regulation of metalloproteinase inhibitor (TIMP.), by oncostatin M in fibroblasts in culture. J Immunol 150:5596-5603.
43. 43. Maier R, Ganu V, Lotz M (1993) Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 268:21527-21532.
44. 44. Ito A, Itoh Y, Sasaguri Y, Morimatsu M, Mori Y (1992) Effects of Interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum 35:1197-1201.
45. 45. Lotz M, Guerne PA (1991) Interleukin 6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1-BPA). J Biol Chem 266:2017-2020.
46. 46. Harvey MB, Leco KJ, Arcellana-Panlileo MY, Zhang X, Edwards DR, Schultz GA (1995) Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development 121:1005-1014.
47. 47. Hamilton JA, Leizber T, Piccoli DS, Royston KM, Butler DM, Croaito M (1991) Oncostatin M stimulates urokinase type plasminogen activator activity in human synovial fibroblasts. Biochem Biophys Res Commun 180:652-659.
48. 48. Villiger P, Geng Yu, Lotz M (1993) Induction of cytokine expression by leukaemia inhibitory factor. J Clin Invest 91:1575-1581.
49. 49. Houssiau FA, Devogelaer J-P, van Damme J, Nagant de Deuxchaisnes C, van Snick J (1988) Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritis. Arthritis Rheum 31:784-788.
50. 50. Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D (1993) Increased levels of leukaemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 36:911-915.
51. 51. Farndale RW, Buttle DJ (1985) Improved quantitation and discrimination of sulphated glycosaminoglycans by the use of dimethylmethylene blue. Biochem Biophys Acta 883:173-177.